Results 221 to 230 of about 12,531 (249)

Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF

JACC: Heart Failure, 2021
Daniel Burkhoff, Barry A Borlaug, Sanjiv J Shah   +2 more
exaly  

Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use

Journal of Cardiovascular Pharmacology, 2020
Zoltán Papp, Piergiuseppe Agostoni, Dominique Bettex   +2 more
exaly  

Effect of Levosimendan on the Short-Term Clinical Course of Patients With Acutely Decompensated Heart Failure

JACC: Heart Failure, 2013
Milton Packer, John R Teerlink, James B Young   +2 more
exaly  

Levosimendan

Reactions Weekly, 2020
openaire   +2 more sources

Levosimendan

Drugs of the Future, 2000
null Toller, W.G., null Pagel, P.S., null Kersten, J.R., null Warltier, D.C.   +3 more
openaire   +1 more source

Levosimendan: Molecular mechanisms and clinical implications

International Journal of Cardiology, 2012
Zoltán Papp, Stefan G De Hert, Alexandre Mebazaa   +2 more
exaly  

Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies*

Critical Care Medicine, 2012
Giovanni Landoni, Giuseppe Biondi-Zoccai, Massimiliano Greco   +2 more
exaly  

Levosimendan vs. dobutamine: outcomes for acute heart failure patients on β‐blockers in SURVIVE†

European Journal of Heart Failure, 2009
Alexandre Mebazaa, John G Cleland
exaly  

Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paper

International Journal of Cardiology, 2016
Dimitrios Farmakis, Tuvia Ben Gal, Dulce Brito   +2 more
exaly  

Levosimendan for Prevention of Acute Kidney Injury After Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials

American Journal of Kidney Diseases, 2016
Chenghui Zhou, Dong Chen
exaly